1072 related articles for article (PubMed ID: 30814291)
1. A Noncanonical Function of Polycomb Repressive Complexes Promotes Human Cytomegalovirus Lytic DNA Replication and Serves as a Novel Cellular Target for Antiviral Intervention.
Svrlanska A; Reichel A; Schilling EM; Scherer M; Stamminger T; Reuter N
J Virol; 2019 May; 93(9):. PubMed ID: 30814291
[TBL] [Abstract][Full Text] [Related]
2. Association of BMI1 with polycomb bodies is dynamic and requires PRC2/EZH2 and the maintenance DNA methyltransferase DNMT1.
Hernández-Muñoz I; Taghavi P; Kuijl C; Neefjes J; van Lohuizen M
Mol Cell Biol; 2005 Dec; 25(24):11047-58. PubMed ID: 16314526
[TBL] [Abstract][Full Text] [Related]
3. Targeted Degradation of PRC1 Components, BMI1 and RING1B, via a Novel Protein Complex Degrader Strategy.
Park KS; Qin L; Kabir M; Luo K; Dale B; Zhong Y; Kim A; Wang GG; Kaniskan HÜ; Jin J
Adv Sci (Weinh); 2023 Apr; 10(10):e2205573. PubMed ID: 36737841
[TBL] [Abstract][Full Text] [Related]
4. Polycomb repressive complex 2 silences human cytomegalovirus transcription in quiescent infection models.
Abraham CG; Kulesza CA
J Virol; 2013 Dec; 87(24):13193-205. PubMed ID: 24067968
[TBL] [Abstract][Full Text] [Related]
5. Kicking against the PRCs - A Domesticated Transposase Antagonises Silencing Mediated by Polycomb Group Proteins and Is an Accessory Component of Polycomb Repressive Complex 2.
Liang SC; Hartwig B; Perera P; Mora-García S; de Leau E; Thornton H; de Lima Alves F; Rappsilber J; Yang S; James GV; Schneeberger K; Finnegan EJ; Turck F; Goodrich J
PLoS Genet; 2015 Dec; 11(12):e1005660. PubMed ID: 26642436
[TBL] [Abstract][Full Text] [Related]
6. The Role of Polycomb Group Protein BMI1 in DNA Repair and Genomic Stability.
Fitieh A; Locke AJ; Motamedi M; Ismail IH
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33804165
[TBL] [Abstract][Full Text] [Related]
7. Polycomb repressive complex 2 (PRC2) suppresses Eμ-myc lymphoma.
Lee SC; Phipson B; Hyland CD; Leong HS; Allan RS; Lun A; Hilton DJ; Nutt SL; Blewitt ME; Smyth GK; Alexander WS; Majewski IJ
Blood; 2013 Oct; 122(15):2654-63. PubMed ID: 23982173
[TBL] [Abstract][Full Text] [Related]
8. Molecular architecture of polycomb repressive complexes.
Chittock EC; Latwiel S; Miller TC; Müller CW
Biochem Soc Trans; 2017 Feb; 45(1):193-205. PubMed ID: 28202673
[TBL] [Abstract][Full Text] [Related]
9. Polycomb group protein-associated chromatin is reproduced in post-mitotic G1 phase and is required for S phase progression.
Aoto T; Saitoh N; Sakamoto Y; Watanabe S; Nakao M
J Biol Chem; 2008 Jul; 283(27):18905-15. PubMed ID: 18453536
[TBL] [Abstract][Full Text] [Related]
10. The downregulation of GFI1 by the EZH2-NDY1/KDM2B-JARID2 axis and by human cytomegalovirus (HCMV) associated factors allows the activation of the HCMV major IE promoter and the transition to productive infection.
Sourvinos G; Morou A; Sanidas I; Codruta I; Ezell SA; Doxaki C; Kampranis SC; Kottakis F; Tsichlis PN
PLoS Pathog; 2014 May; 10(5):e1004136. PubMed ID: 24830456
[TBL] [Abstract][Full Text] [Related]
11. Histone H2AK119 Mono-Ubiquitination Is Essential for Polycomb-Mediated Transcriptional Repression.
Tamburri S; Lavarone E; Fernández-Pérez D; Conway E; Zanotti M; Manganaro D; Pasini D
Mol Cell; 2020 Feb; 77(4):840-856.e5. PubMed ID: 31883952
[TBL] [Abstract][Full Text] [Related]
12. Polycomb repressive complex's evolutionary conserved function: the role of EZH2 status and cellular background.
Gall Trošelj K; Novak Kujundzic R; Ugarkovic D
Clin Epigenetics; 2016; 8():55. PubMed ID: 27239242
[TBL] [Abstract][Full Text] [Related]
13. Critical Roles of Polycomb Repressive Complexes in Transcription and Cancer.
Dong GJ; Xu JL; Qi YR; Yuan ZQ; Zhao W
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36076977
[TBL] [Abstract][Full Text] [Related]
14. The role of the polycomb repressive complex pathway in T and NK cell lymphoma: biological and prognostic implications.
Kim SH; Yang WI; Min YH; Ko YH; Yoon SO
Tumour Biol; 2016 Feb; 37(2):2037-47. PubMed ID: 26337274
[TBL] [Abstract][Full Text] [Related]
15. The Bmi-1 polycomb protein antagonizes the (-)-epigallocatechin-3-gallate-dependent suppression of skin cancer cell survival.
Balasubramanian S; Adhikary G; Eckert RL
Carcinogenesis; 2010 Mar; 31(3):496-503. PubMed ID: 20015867
[TBL] [Abstract][Full Text] [Related]
16. MiR-203 Interplays with Polycomb Repressive Complexes to Regulate the Proliferation of Neural Stem/Progenitor Cells.
Liu PP; Tang GB; Xu YJ; Zeng YQ; Zhang SF; Du HZ; Teng ZQ; Liu CM
Stem Cell Reports; 2017 Jul; 9(1):190-202. PubMed ID: 28602614
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors of the Histone Methyltransferases EZH2/1 Induce a Potent Antiviral State and Suppress Infection by Diverse Viral Pathogens.
Arbuckle JH; Gardina PJ; Gordon DN; Hickman HD; Yewdell JW; Pierson TC; Myers TG; Kristie TM
mBio; 2017 Aug; 8(4):. PubMed ID: 28811345
[TBL] [Abstract][Full Text] [Related]
18. Polycomb repressive complex 2 targets murine cytomegalovirus chromatin for modification and associates with viral replication centers.
Abraham CG; Kulesza CA
PLoS One; 2012; 7(1):e29410. PubMed ID: 22279536
[TBL] [Abstract][Full Text] [Related]
19. Canonical PRC1 controls sequence-independent propagation of Polycomb-mediated gene silencing.
Moussa HF; Bsteh D; Yelagandula R; Pribitzer C; Stecher K; Bartalska K; Michetti L; Wang J; Zepeda-Martinez JA; Elling U; Stuckey JI; James LI; Frye SV; Bell O
Nat Commun; 2019 Apr; 10(1):1931. PubMed ID: 31036804
[TBL] [Abstract][Full Text] [Related]
20. Polycomb repressor complex: Its function in human cancer and therapeutic target strategy.
Liu J; Fan H; Liang X; Chen Y
Biomed Pharmacother; 2023 Dec; 169():115897. PubMed ID: 37981459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
